4.7 Article

Generation of multicellular tumor spheroids with micro-well array for anticancer drug combination screening based on a valuable biomarker of hepatocellular carcinoma

Related references

Note: Only part of the references are listed.
Article Engineering, Biomedical

Fibrinogen improves liver function via promoting cell aggregation and fibronectin assembly in hepatic spheroids

Ruihong Li et al.

Summary: The liver functions depend on interactions between parenchymal cells and the microenvironment, with biological macromolecules in the matrix playing a key role. Rat liver biomatrix scaffold prepared from adult rats is more effective in enhancing hepatic spheroid function. Fibronectin and fibrinogen show potential for improving hepatocyte function, promoting cell aggregation and activating Wnt/beta-catenin pathway.

BIOMATERIALS (2022)

Review Oncology

Immunotherapies for hepatocellular carcinoma

Josep M. Llovet et al.

Summary: Liver cancer, specifically hepatocellular carcinoma (HCC), is the second leading cause of cancer-related death globally. Traditional treatments involve specific drugs, but the emergence of immune checkpoint inhibitors has revolutionized the management of HCC.

NATURE REVIEWS CLINICAL ONCOLOGY (2022)

Article Biochemistry & Molecular Biology

Therapeutic target database update 2022: facilitating drug discovery with enriched comparative data of targeted agents

Ying Zhou et al.

Summary: Drug discovery relies not only on knowledge of drugs and targets, but also on understanding comparative agents and targets. This study introduces a major update to the Therapeutic Target Database, providing valuable data on poor binders, non-binders, prodrug-drug pairs, co-targets, and drug-like properties, as well as additional features for advanced search and cross-links to target structures. The database is accessible without login requirement at: https://idrblab.org/ttd/.

NUCLEIC ACIDS RESEARCH (2022)

Article Cell Biology

High-content imaging of human hepatic spheroids for researching the mechanism of duloxetine-induced hepatotoxicity

Juan Liu et al.

Summary: This study used a human-simulated hepatic spheroid model to demonstrate that Duloxetine (DLX)-induced liver injury is a human CYP450 specific, metabolism-dependent, oxidative stress triggered complex hepatic injury. They also discovered that a novel compound S-071031B showed lower hepatotoxicities than DLX. This research presents the human-relevant model as an ideal system for evaluating DLX-induced hepatotoxicity and exploring related mechanisms.

CELL DEATH & DISEASE (2022)

Article Oncology

Parthenolide inhibits the tumor characteristics of renal cell carcinoma

Dandan Liu et al.

Summary: Parthenolide has been shown to have anti-cancer effects against various types of cancer. This study investigated the effects of parthenolide on RCC 786-O and ACHN cells, finding that it inhibited cell proliferation and metastasis and suppressed stem cell-like properties. Further research on the molecular mechanisms of parthenolide in RCC is needed in the future.

INTERNATIONAL JOURNAL OF ONCOLOGY (2021)

Article Biochemistry & Molecular Biology

The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets

Damian Szklarczyk et al.

Summary: The STRING database integrates various associations between proteins, including physical interactions and functional associations, by collecting evidence from sources such as literature, databases, computational predictions, and systematic transfers. STRING aims for wide coverage and provides extensive user interface features and querying methods for experimental data.

NUCLEIC ACIDS RESEARCH (2021)

Article Medicine, General & Internal

Hepatocellular carcinoma

Josep M. Llovet et al.

Summary: Liver cancer, particularly hepatocellular carcinoma (HCC), poses a significant global health challenge with rising incidence projected to exceed 1 million cases by 2025. Infection by hepatitis B and C viruses remains a major risk factor for HCC, while non-alcoholic steatohepatitis is emerging as a more common risk factor in Western countries. Advances in systemic therapies for HCC, including immunotherapies and targeted therapies, are expected to revolutionize the management of this disease.

NATURE REVIEWS DISEASE PRIMERS (2021)

Article Chemistry, Medicinal

Parthenolide Derivatives as PKM2 Activators Showing Potential in Colorectal Cancer

Xingchen Liu et al.

Summary: In this study, a potential drug candidate 29e for treating CRC was designed to inhibit tumor growth by targeting PKM2 kinase, demonstrating significant antiproliferative effects in cell experiments and animal models.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Biochemistry & Molecular Biology

HIF-1α-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation

Qing Li et al.

Summary: YTHDF1 plays a key role in hepatocellular carcinoma, with its expression level correlated to hypoxia-induced autophagy, tumor growth, and metastasis, serving as an independent prognostic factor. HIF-1 alpha regulates YTHDF1 transcription under hypoxia to promote translation of autophagy-related genes, contributing to autophagy and malignancy in HCC progression.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Review Biochemistry & Molecular Biology

Parthenolide and its Analogues: A New Potential Strategy for the Treatment of Triple-Negative Breast Tumors

Thaise Goncalves Araujo et al.

CURRENT MEDICINAL CHEMISTRY (2020)

Review Biochemistry & Molecular Biology

FGF/FGFR signaling in health and disease

Yangli Xie et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Review Cell Biology

FGF19-FGFR4 Signaling in Hepatocellular Carcinoma

Aroosha Raja et al.

CELLS (2019)

Review Gastroenterology & Hepatology

A global view of hepatocellular carcinoma: trends, risk, prevention and management

Ju Dong Yang et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)

Article Biochemistry & Molecular Biology

DrugBank 5.0: a major update to the DrugBank database for 2018

David S. Wishart et al.

NUCLEIC ACIDS RESEARCH (2018)

Article Biochemistry & Molecular Biology

SIRT5 inhibits peroxisomal ACOX1 to prevent oxidative damage and is downregulated in liver cancer

Xiu-Fei Chen et al.

EMBO REPORTS (2018)

Article Biochemical Research Methods

DeepSynergy: predicting anti-cancer drug synergy with Deep Learning

Kristina Preuer et al.

BIOINFORMATICS (2018)

Letter Biochemistry & Molecular Biology

The Drug Repurposing Hub: a next-generation drug library and information resource

Steven M. Corsello et al.

NATURE MEDICINE (2017)

Article Biochemistry & Molecular Biology

GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses

Zefang Tang et al.

NUCLEIC ACIDS RESEARCH (2017)

Review Oncology

Fibroblast growth factor signalling: from development to cancer

Nicholas Turner et al.

NATURE REVIEWS CANCER (2010)

Article Biochemical Research Methods

Scaffold-free three-dimensional cell culture utilizing micromolded nonadhesive hydrogels

Anthony P. Napolitano et al.

BIOTECHNIQUES (2007)